Information for "Omigapil"
Basic information
| Display title | Omigapil |
| Default sort key | Omigapil |
| Page length (in bytes) | 21,123 |
| Namespace ID | 0 |
| Page ID | 3139976 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of page watchers | Fewer than 30 watchers |
| Number of redirects to this page | 2 |
| Counted as a content page | Yes |
| Wikidata item ID | Q7090184 |
| Local description | Drug developed by Novartis |
| Central description | chemical compound |
| Page image |  |
| Page views in the past 30 days |
Page protection
| Edit | Allow all users (no expiry set) |
| Move | Allow all users (no expiry set) |
Edit history
| Page creator | 66.68.91.129 (talk) |
| Date of page creation | 05:14, 12 November 2005 |
| Latest editor | InternetArchiveBot (talk | contribs) |
| Date of latest edit | 08:35, 27 March 2024 |
| Total number of edits | 96 |
| Recent number of edits (within past 30 days) | 0 |
| Recent number of distinct authors | 0 |
Page properties
Lint errors
| Duplicate IDs | 4 |
| Background color inline style rule exists without a corresponding text color | 1 |